📌 Key Takeaways
- Topic: What Is Fused Silica Sand? Properties and Uses in Investment Casting and Refractories
- Keywords: crystalline silica dust hazard
- Published: 2026-11-20 04:30:50
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Hollow Silica? Structure, Properties and Applications
- What Is Silicon Oxide? SiO vs SiO₂ Differences and Applications Explained
- Controlling the drug delivery of MSNs
- What Is Microsilica? Composition, Benefits and How It Improves Concrete Strength
- He, Q., Shi, J., Zhu, M., Chen, Y. & Chen, F. The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluid. Micropor. Mesopor. Mater. 131, 314-320 (2010). Piece CAS Google Scholar
- Food Grade Silica: Specifications, E551 Status and Uses as an Anti-Caking Agent
- Amorphous vs Crystalline Silica: Structure, Safety and Uses Compared
Silica for Wafer Polishing: Slurry Types, Particle Size and Performance
What is silica (SiO₂)?
Cab-O-Sil alternative Targeted delivery tactics are generally divided into two categories: passive targeting and active targeting. Passive targeting relies on the pathological qualities of the disease microenvironment and the nature of the drug delivery system itself, which allows the drug to effectively accumulate at the lesion site of disease. The most well-known passive targeting is the EPR effect of tumor, which refers to the phenomenon that some particles with particular size (20-200 nm) penetrate more without difficulty into tumor tissue and remain there for a long time when compared to normal tissue. 316, 317 Therefore, controlling the size of MSNs to a fitting range will facilitate their enrichment in the tumor sites. However, it has also been highlighted that the passive targeting strategy relying on the EPR effect can attain only 0.7% of the injected NPs enrichment in solid tumors, 318 which will not be handy for the clinical translation of nanotechnology. In contrast, active targeting relies on the active recognition between the molecules on the NPs surface and the specific molecules or proteins in the illness microenvironment, which is also referred to as ligand-receptor specific binding. 319 The active targeting shows a higher drug delivery efficiency compared to passive targeting. 320 Targeted ligands, such as proteins, antibodies, peptides, nucleic acids and chemical tiny molecules, can be modified on the surface of MSNs, and the modified MSNs are capable of selectively aggregating at the lesion site based on the powerful affinity between the targeted ligands and the particular receptors overexpressed in the sickness microenvironment. 321, 322, 323, 324 For instance, compared to mature vascular endothelial cells, tumor neovascular endothelial cells are highly expressed in an array of proteins, such as integrins, transmembrane glycoproteins and aminopeptidase N. Molecules that recognize these highly expressed proteins can be used for neovascular-based targeted drug delivery. A standard example is that arginylglycylaspartic acid (RGD)-modified MSNs can selectively bind integrin α ν β 3 receptor and hence be applied to target tumor neovascularization. 325
What is the difference between fumed silica and precipitated silica?
silica dielectric constant Wu, H. et al. Ceria nanocrystals decorated mesoporous silica nanoparticle based ROS-scavenging tissue adhesive for highly productive regenerative wound healing. Biomaterials 151, 66-77 (2018). Piece CAS PubMed Google Scholar
What drives silica raw material prices?
microsilica for cement MSNs are a kind of relatively inert inorganic nanomaterials and are less frequently used as functional components for bioimaging or therapeutic purposes. However, as mentioned above, the features of MSNs including the high specific surface area, tunable pore size, controlled morphology and high mechanical/thermal stability, as well as superb biosafety and biodegradability, make them excellent substrate materials for the construction of a wide range of nanocomposites. 110, 111, 112, 113, 114 Through the host-guest assembly process, different kinds of inorganic functional components can be introduced to give the nanocomposites new physicochemical properties, such as magnetic-, light- and ultrasonic-response properties. 115, 116, 117, 118, 119 Depending on the assembly strategy, particular nanostructured composites can be gained, and there are five chief types of MSNs-based nanocomposites (Fig. 4a ): (1) Type I: Core-shell architectures, 120 where the MSNs act as the inner core and the functional components as the outer shell. The functional nanoshells with specific sizes can be without difficulty obtained by manipulating MSNs hard template. (2) Type II: Small-sized functional components loaded directly into the pores of MSNs. The common functional components such as carbon quantum dots and black phosphorus quantum dots are often encapsulated into MSNs in this form. In this architecture, MSNs enable slow and controlled release of small-sized functional elements. (3) Type III: The functional component is loaded directly onto the surface of MSNs or on the periphery of the pore channel through covalent bonding or electrostatic adsorption. A distinct benefit of the Type III architecture is that it does not mask the active sites of the functional factors, ensuring their catalytic stability. (4) Type IV: Core-shell architectures, 116, 121, 122 but in which the MSNs act as the outer shell and the functional component acts as the inner core. Type IV architecture can stay away from the aggregation of bare inorganic functional components, and afford the nanocomposites enhanced stability and decreased physiological toxicity. A common example is the upconversion NPs@MSNs nanocomposites, in which the MSNs are also often loaded with photosensitizers to synergize with the upconversion NPs for PDT. 122 (5) Type V: Janus-type architectures. Janus-type nanocomposites have the biphasic geometries with distinct compositions or anisotropic structures, and the physicochemical properties between the individual components are mostly unaffected, 123 in contrast to the aforementioned Type I-IV nanocomposites.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.